Chargement en cours...
Epoetin Therapy and Hemoglobin Level Variability in Nondialysis Patients with Chronic Kidney Disease
Background and objectives: Intrapatient variability of hemoglobin (Hb) is a newly proposed determinant of adverse outcome in chronic kidney disease (CKD). We evaluated whether intensity of epoetin therapy affects Hb variability and renal survival in nondialysis CKD. Design, setting, participants, &a...
Enregistré dans:
| Auteurs principaux: | , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
American Society of Nephrology
2009
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2653671/ https://ncbi.nlm.nih.gov/pubmed/19261821 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2215/CJN.04380808 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|